IGF1 and breast cancer: Exogenous IGFBP-3 treatment to Hs578T breast cancer cells lacking IGF-1R was demonstrated to have little effect on the inhibition of growth, however, treatment with an analog of ceramide could dramatically enhance apoptosis in an IGF-independent manner (Perks et al., 1999).